Literature DB >> 1723639

Basic fibroblast growth factor promotes in vivo cerebral angiogenesis in chronic forebrain ischemia.

M K Lyons1, R E Anderson, F B Meyer.   

Abstract

This experiment was designed to determine if intraventricular administration of basic fibroblast growth factor (bFGF) could promote cerebral angiogenesis in a model of mild chronic forebrain ischemia. Wistar rats underwent bilateral carotid artery ligation. Animals received intraventricular injections of bFGF every 4 days for 28 days. Basic fibroblast growth factor caused a significant dose-dependent increase in capillary density compared to ischemic controls in all regions examined. These results support the hypothesis that chronic intraventricular administration of bFGF induces in vivo cerebral angiogenesis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1723639     DOI: 10.1016/0006-8993(91)90784-s

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  4 in total

Review 1.  Blood-brain barrier transport of therapeutics via receptor-mediation.

Authors:  Angela R Jones; Eric V Shusta
Journal:  Pharm Res       Date:  2007-07-10       Impact factor: 4.200

2.  Non-moyamoya vessel network formation along steno-occlusive middle cerebral artery.

Authors:  Yu-Yuan Xu; Ming-Li Li; Shan Gao; Bo Hou; Zhao-Yong Sun; Hai-Long Zhou; Feng Feng; Wei-Hai Xu
Journal:  Neurology       Date:  2016-04-27       Impact factor: 9.910

3.  Ischemia/Reperfusion-induced neovascularization in the cerebral cortex of the ovine fetus.

Authors:  Daniela Virgintino; Francesco Girolamo; Marco Rizzi; Nigar Ahmedli; Grazyna B Sadowska; Edward G Stopa; Jiyong Zhang; Barbara S Stonestreet
Journal:  J Neuropathol Exp Neurol       Date:  2014-06       Impact factor: 3.685

Review 4.  Hypoxic-ischemic-related cerebrovascular changes and potential therapeutic strategies in the neonatal brain.

Authors:  Clémence Disdier; Barbara S Stonestreet
Journal:  J Neurosci Res       Date:  2020-02-14       Impact factor: 4.164

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.